Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Immunology Year : 2022

Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation

(1) , (1) , (2) , (3) , (4) , (4) , (4) , (5, 6) , (5, 6) , (3) , (1) , (2) , (1) , (1)
1
2
3
4
5
6

Abstract

W614A-3S peptide is a modified 3S motif of the HIV-gp41 (mutation W614A). We previously detected the presence of natural neutralizing antibodies directed against W614A-3S peptide (NAbs) in long-term non-progressor HIV + patients. Here, we compared the efficacy of W614A-3S peptide formulated in either squalene emulsion (SQE) or in aluminum hydroxide (Alum) in inducing broadly-NAbs (bNAbs). Rabbit and mouse models were used to screen the induction of bNAbs following 4 immunizations. SQE was more efficient than Alum formulation in inducing W614A-3S-specific bNAbs with up to 67%–93% of HIV strains neutralized. We then analyzed the quality of peptide-specific murine B cells by single-cell gene expression by quantitative reverse transcription-PCR and single-cell V(D)J sequencing. We found more frequent germinal center B cells in SQE than in Alum, albeit with a different gene expression profile. The V(D)J sequencing of W614A-3S-specific BCR showed significant differences in BCR sequences and validates the dichotomy between adjuvant formulations. All sixteen BCR sequences which were cloned were specific of peptide. Adjuvant formulations of W614A-3S-peptide-conjugated immunogen impact the quantity and quality of B cell immune responses at both the gene expression level and BCR sequence.

Dates and versions

hal-03745736 , version 1 (04-08-2022)

Identifiers

Cite

Olivia Bonduelle, Chloé Chaudesaigues, Monica Tolazzi, Ehsan Suleiman, Simon de Bernard, et al.. Dichotomy in Neutralizing Antibody Induction to Peptide-Conjugated Vaccine in Squalene Emulsion Contrast With Aluminum Hydroxide Formulation. Frontiers in Immunology, 2022, 13, pp.848571. ⟨10.3389/fimmu.2022.848571⟩. ⟨hal-03745736⟩
7 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More